Copyright
©The Author(s) 2019.
World J Diabetes. Nov 15, 2019; 10(11): 534-545
Published online Nov 15, 2019. doi: 10.4239/wjd.v10.i11.534
Published online Nov 15, 2019. doi: 10.4239/wjd.v10.i11.534
Table 1 Genetic ancestry of type 1 diabetes patients compared to Colombians living in Medellin control population
Chromosomal region | Ancestry | T1D, median (IQR) | CLM, median (IQR) | P value1 |
Overall AIMs | EUR | 61.58 (52.84-69.85) | 62.06 (49.67-73.74) | 0.675 |
NAT | 27.34 (21.36-34.05) | 25.46 (16.12- 32.90) | 0.106 | |
AFR | 10.28 (4.0-16.83) | 10.65 (6.05-16.75) | 0.575 | |
Chr2_EFR3B | EUR | 60.27 (34.05-80.79) | 47.88 (34.04-76.43) | 0.189 |
NAT | 24.30 (0.01-51.24) | 37.10 (1.61-62.49) | 0.02 | |
AFR | 7.17 (0.01-25.05) | 0.01 (0.01-15.67) | 0.06 | |
Chr2_CTLA4 | EUR | 46.24 (16.82-69.52) | 58.26 (30.82-82.79) | 0.167 |
NAT | 27.96 (0.04-41.31) | 25.01 (0.01-45.16) | 0.829 | |
AFR | 20.54 (0.01-41.72) | 11.78 (0.01-36.59) | 0.183 | |
Chr2_RNASEH1 | EUR | 56.91 (31.33-73.91) | 58.80 (32.75-78.43) | 0.482 |
NAT | 27.41 (11.69-46.36) | 24.81 (0.01-48.84) | 0.241 | |
AFR | 8.37 (0.01-28.24) | 13.04 (0.01-23.87) | 0.430 | |
Chr2_IFIH1 | EUR | 42.42 (0.01-77.63) | 52.01 (16.33-82.16) | 0.05 |
NAT | 32.07 (0.01-56.74) | 14.99 (0.01-41.35) | 0.246 | |
AFR | 14.99 (0.01-32.31) | 17.83 (0.01-42.31) | 0.181 | |
Chr5_IL7R | EUR | 11.56 (1.04-41.14) | 24.75 (7.20-46.98) | 7.0 × 10-3 |
NAT | 52.18 (3.74-98.06) | 39.18 (0.04-52.80) | 1.0 × 10-4 | |
AFR | 15.21 (3.0-35.75) | 33.89 (11.23-59.94) | 1.56 × 10-5 | |
Chr6_MHC | EUR | 51.35 (32.92-70.32) | 55.86 (32.61-71.21) | 0.76 |
NAT | 23.28 (8.92-40.0) | 21.61 (5.83-43.13) | 0.835 | |
AFR | 18.87 (1.63-36.08) | 19.53 (0.3-34.11) | 0.660 | |
Chr10_NRP1 | EUR | 63.32 (23.70-63.32) | 0.03 (0.001-20.34) | 2.2 × 10-16 |
NAT | 36.67 (7.93-36.67) | 0.003 (0.001-7.93) | 2.2 × 10-16 | |
AFR | 0.03 (0.001-30.91) | 94.23 (53.94-99.99) | 2.2 × 10-16 |
Table 2 Significant findings in an exploratory association analysis
CHR | SNP | A1 | MAF | ORa | 95%CI | P value1 | EMP1 | |
T1D | CLM | |||||||
2 | rs798364 | A | 0.18 | 0.27 | 0.62 | 0.40-0.96 | 0.034 | 0.035 |
2 | rs1606237 | T | 0.33 | 0.26 | 1.55 | 1.04-2.30 | 0.031 | 0.031 |
5 | rs700164 | T | 0.56 | 0.35 | 2.38 | 1.62-3.48 | 5.56 × 10-6 | 3.0 × 10-6 |
6 | rs9378428 | C | 0.38 | 0.48 | 0.61 | 0.42-0.89 | 0.010 | 0.018 |
6 | rs2523747 | G | 0.42 | 0.30 | 1.68 | 1.13-2.51 | 0.010 | 0.012 |
6 | rs2395656 | G | 0.23 | 0.28 | 0.63 | 0.41-0.98 | 0.040 | 0.041 |
10 | rs3123687 | G | 0.15 | 0.86 | 0.04 | 0.02-0.08 | 8.70 × 10-19 | 1.0 × 10-6 |
Table 3 Genetic ancestry for type 1 diabetes patients stratified according to autoimmunity
Chromosomal region | Ancestry | T1AD, median (IQR) | T1BD, median (IQR) | P value1 |
Overall AIMs | EUR | 61.92 (53.57-70.89) | 59.79 (49.70-68.03) | 0.333 |
NAT | 27.07 (20.82-33.48) | 29.16 (21.57-37.06) | 0.312 | |
AFR | 10.19 (2.88-16.01) | 11.54 (5.55-17.80) | 0.344 | |
Chr2_EFR3B | EUR | 60.28 (36.24-83.66) | 59.79 (32.34-80.01) | 0.551 |
NAT | 25.16 (0.01-51.24) | 21.92 (0.01-45.95) | 0.979 | |
AFR | 4.53 (0.01-23.32 | 14.41 (0.01-27.36) | 0.119 | |
Chr2_CTLA4 | EUR | 53.34 (16.82-70.53) | 41.16 (16.62-60.86) | 0.231 |
NAT | 26.28 (4.55-41.31) | 32.69 (9.35-50.25) | 0.343 | |
AFR | 20.54 (0.01-41.73) | 19.47 (0.01-42.52) | 0.764 | |
Chr2_RNASEH1 | EUR | 58.96 (37.72-73.87) | 47.50 (26.38-78.10) | 0.506 |
NAT | 26.92 (14.19-45.66) | 31.59 (0.01-51.98) | 0.885 | |
AFR | 6.85 (0.01-28.24) | 11.71 (0.01-27.86) | 0.657 | |
Chr2_IFIH1 | EUR | 41.90 (0.01-76.72) | 42.42 (0.01-67.93) | 0.708 |
NAT | 32.56 (0.01-55.56) | 27.39 (2.01-56.89) | 0.985 | |
AFR | 14.99 (0.01-42.31) | 0.01 (0.01-36.48) | 0.654 | |
Chr5_IL7R | EUR | 13.27 (1.02-43.73) | 9.19 (1.77-33.67) | 0.555 |
NAT | 50.94 (38.08-98.60) | 53.12 (31.82-95.13) | 0.984 | |
AFR | 14.68 (3.17-33.94) | 17.98 (2.75-41.01) | 0.634 | |
Chr6_MHC | EUR | 52.31 (37.26-72.43) | 45.73 (19.25-67.03) | 0.087 |
NAT | 20.32 (7.12-37.06) | 31.88 (17.65-44.62) | 0.019 | |
AFR | 18.50 (3.21-36.04) | 21.13 (0.53-36.56) | 0.905 | |
Chr10_NRP1 | EUR | 63.32 (28.61-69.09) | 63.31 (6.89-63.32) | 0.092 |
NAT | 36.67 (7.93-36.67) | 36.67 (7.93-59.79) | 0.282 | |
AFR | 0.25 (1e-05-26.0) | 0.52 (1e-05-37.80) | 0.848 |
Table 4 Genetic ancestry for type 1 diabetes patients stratified according to age at onset
Chromosomal region | Ancestry | Early age at onset, ≤ 5 yr | Late age at onset, > 5 yr | P value1 |
Overall AIMs | EUR | 62.06 (54.50-71.38) | 61.12 (51.66-68.68) | 0.420 |
NAT | 25.40 (18.14-33.55) | 27.75 (21.86-34.35) | 0.345 | |
AFR | 11.09 (3.90-17.25) | 10.19 (3.88-16.91) | 0.927 | |
Chr2_EFR3B | EUR | 57.65 (34.05-82.17) | 62.45 (42.04-80.67) | 0.419 |
NAT | 25.16 (1.27-52.11) | 24.30 (0.01-51.73) | 0.607 | |
AFR | 5.02 (0.01-27.29) | 7.37 (0.01 23.32) | 0.941 | |
Chr2_CTLA4 | EUR | 58.49 (24.63-78.80) | 46.09 (12.90-66.30) | 0.180 |
NAT | 26.28 (3.98-39.82) | 30.19 (4.55-42.10) | 0.362 | |
AFR | 18.05 (0.01-37.80) | 20.68 (0.01-41.72) | 0.701 | |
Chr2_RNASEH1 | EUR | 56.84 (44.50-72.18) | 56.91 (28.02-74.15) | 0.672 |
NAT | 27.22 (0.01-31.22) | 28.03 (8.15-48.58) | 0.472 | |
AFR | 3.38 (0.01-31.22) | 8.62 (0.01-27.20) | 0.917 | |
Chr2_IFIH1 | EUR | 41.35 (0.01-66.94) | 42.42 (4.44-76.73) | 0.126 |
NAT | 33.05 (0.67-57.49) | 29.05 (0.01-53.09) | 0.339 | |
AFR | 14.57 (0.01-42.31) | 1.01 (0.01-42.31) | 0.796 | |
Chr5_IL7R | EUR | 9.38 (0.33-41.70) | 12.86 (1.73-43.11) | 0.338 |
NAT | 53.83 (39.76-99.60) | 50.94 (30.21-88.75) | 0.197 | |
AFR | 6.17 (1.01-29.03) | 19.96 (9.6-37.36) | 0.023 | |
Chr6_MHC | EUR | 51.67 (32.23-63.29) | 52.07 (34.26-71.84) | 0.596 |
NAT | 30.57 (13.47-43.21) | 26.71 (7.69-37.39) | 0.480 | |
AFR | 15.03 (4.46-36.05) | 20.52 (1.08-36.73) | 0.118 | |
Chr10_NRP1 | EUR | 63.32 (23.70-63) | 63.32(43.07-69.08) | 0.357 |
NAT | 36.68 (7.93-36.67) | 36.67 (7.93-36.68) | 0.797 | |
AFR | 0.16 (0.001-39-1) | 0.38 (0.001-63.3) | 0.498 |
- Citation: Gomez-Lopera N, Alfaro JM, Leal SM, Pineda-Trujillo N. Type 1 diabetes loci display a variety of native American and African ancestries in diseased individuals from Northwest Colombia. World J Diabetes 2019; 10(11): 534-545
- URL: https://www.wjgnet.com/1948-9358/full/v10/i11/534.htm
- DOI: https://dx.doi.org/10.4239/wjd.v10.i11.534